Thus, this study was designed to evaluate the Gly482Ser polymorphism (rs8192678) within the PPARGC1A gene and its association with the increased risk of NAFLD in Iranian patients with type 2 diabetes. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.